0       0

Optimizing Immunosuppression in Liver Transplant Recipients


002 - Immunosuppression in the setting of viral disease and malignancy


Description

After participating in this activity, the learner will be able to:

  • Explain the effects of various immunosuppressive agents on the recurrence of hepatitis C in liver transplant recipients.
  • Discuss immunosuppressive options with my patients with hepatitis C virus infection.
  • Describe the effects of bolus dose steroids and depleting T cell antibodies on the histological recurrence of HCV after treatment for rejection.

Speaker(s):

  • Michael Curry, MD, Beth Israel Deaconess Medical Center Boston, MA

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content